• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Leavitt Legacy, Llc bought 7,974,481 shares (SEC Form 4)

    6/26/24 4:30:04 PM ET
    $PIII
    Medical/Nursing Services
    Health Care
    Get the next $PIII alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    LEAVITT LEGACY, LLC

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    P3 Health Partners Inc. [ PIII ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/24/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/24/2024 P 7,974,481(1) A (1) 16,919,024 I By Leavitt Equity Partners III, L.P.
    Class A Common Stock 894,454 I By Leavitt Equity Partners II, L.P.
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Warrant $0.502 05/24/2024 P 7,974,481(1) (2) 05/24/2031 Class A Common Stock 7,974,481 (1) 7,974,481 I By Leavitt Equity Partners III, L.P.
    1. Name and Address of Reporting Person*
    LEAVITT LEGACY, LLC

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Leavitt Equity Partners II, L.P.

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Leavitt Equity Partners II, LLC

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Leavitt Equity Partners III, L.P.

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Leavitt Equity Partners III, LLC

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    LEP Management LLC

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    LEAVITT TAYLOR S.

    (Last) (First) (Middle)
    95 SOUTH STATE STREET
    SUITE 2190

    (Street)
    SALT LAKE CITY UT 84111

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The reported securities were issued in connection with the Issuer's sale of 7,974,481 Units purchased by the Reporting Person for $0.6270 per Unit. Each Unit consists of (i) one share of Class A Common Stock and (ii) one warrant to purchase one share of Class A Common Stock. The Units were issued directly to Leavitt Equity Partners III, L.P., of which Leavitt Equity Partners III, LLC is the general partner.
    2. Exercisable Immediately.
    Leavitt Legacy, LLC, By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    Leavitt Equity Partners II, LLC By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    Leavitt Equity Partners II, L.P., By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    Leavitt Equity Partners III, LLC, By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    Leavitt Equity Partners III, L.P., By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    LEP Management, LLC, By: /s/ Taylor Leavitt, authorized signatory 06/26/2024
    /s/ Taylor S. Leavitt 06/26/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $PIII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PIII

    DatePrice TargetRatingAnalyst
    8/28/2025$20.00Buy
    Lake Street
    4/1/2024Buy → Neutral
    BTIG Research
    9/1/2023$5.00Buy
    BTIG Research
    6/30/2023Market Perform
    TD Cowen
    1/4/2022Outperform
    William Blair
    More analyst ratings

    $PIII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO

    New Partnership Strengthens Value-Based Care Platform for Primary Care Providers P3 Health Partners ("P3") (NASDAQ:PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. This partnership brings together two highly aligned organizations with a shared belief in the power of primary care, including independent physicians, and a proven record of success in value-based models. The joint venture also expands P3's footprint into Ma

    12/2/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Announces Third Quarter 2025 Results

    P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. "Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model," said Aric Coffman, CEO of P3. "Medical cost trends

    11/13/25 5:30:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webcast P3 Health Third Quarter 2025 Earnings Conference Call Date & Time November 14, 2025, 8:00am Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 A

    10/21/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on P3 Health Partners with a new price target

    Lake Street resumed coverage of P3 Health Partners with a rating of Buy and set a new price target of $20.00

    8/28/25 8:10:21 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners downgraded by BTIG Research

    BTIG Research downgraded P3 Health Partners from Buy to Neutral

    4/1/24 7:39:12 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on P3 Health Partners with a new price target

    BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00

    9/1/23 7:31:24 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kazarian Gregory N. was granted 2,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 218,561 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:27:25 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Director Tolan Mary A was granted 2,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 218,561 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:23:20 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Director Thierer Mark was granted 4,000 units of Class A Common Stock, increasing direct ownership by 0.92% to 437,121 units (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    8/8/25 7:18:03 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    SEC Filings

    View All

    P3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - P3 Health Partners Inc. (0001832511) (Filer)

    11/28/25 1:29:52 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - P3 Health Partners Inc. (0001832511) (Filer)

    8/29/25 4:17:12 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by P3 Health Partners Inc.

    10-Q - P3 Health Partners Inc. (0001832511) (Filer)

    8/14/25 4:56:15 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/13/24 9:56:09 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $128,624 worth of shares (240,000 units at $0.54) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/12/24 8:12:24 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Large owner Chicago Pacific Founders Ugp Iii, Llc bought $117,544 worth of shares (240,000 units at $0.49) (SEC Form 4)

    4 - P3 Health Partners Inc. (0001832511) (Issuer)

    9/11/24 6:17:20 AM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Leadership Updates

    Live Leadership Updates

    View All

    P3 Health Partners Names Leif Pedersen New Chief Financial Officer

    P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m

    8/29/24 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Names Dr. Aric Coffman as CEO

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici

    5/8/24 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by P3 Health Partners Inc.

    SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

    11/14/24 4:33:46 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

    SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

    11/8/24 5:15:05 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

    SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

    6/26/24 4:30:49 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    $PIII
    Financials

    Live finance-specific insights

    View All

    P3 Health Partners Announces Third Quarter 2025 Results

    P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. "Our core business continues to demonstrate positive momentum in the third quarter, driven by the expansion of our Care Enablement Model," said Aric Coffman, CEO of P3. "Medical cost trends

    11/13/25 5:30:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call

    P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Title & Webcast P3 Health Third Quarter 2025 Earnings Conference Call Date & Time November 14, 2025, 8:00am Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 A

    10/21/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care

    P3 Health Partners Announces Second Quarter 2025 Results

    Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 2026 Adjusted Full Year Guidance Reflects Prior Period Headwinds Management to Host Conference Call and Webcast August 14, 2025 at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2025. "Our core business continues to strengthen as we execute on our $130 million EBITDA improvement plan," said Aric Coffman, CEO of P3. "While we faced prior period head

    8/14/25 4:05:00 PM ET
    $PIII
    Medical/Nursing Services
    Health Care